Medical News

RSS

Drug to prevent brain ageing: Study

A new study shows that some chemicals given to rhesus macaques blocked a brain molecule that slows the firing of the brain's nerve cells, or neurons, as they age—prompting those nerve cells to act young again.

28 Jul 2011

$3 million grant to aid minorities with uncontrolled diabetes

Researchers at the University of Illinois at Chicago's Institute for Health Research and Policy and College of Medicine have received a $3 million federal grant to improve diabetes management in minority patients.

28 Jul 2011

New era of healthcare showcased as NBN switches on in Coastal NSW

Residents in the neighbouring areas of Kiama Downs and Minnamurra, south of Sydney, are set to be the next to experience superfast fibre broadband through the National Broadband Network (NBN) as the first mainland coastal sites go live today.

28 Jul 2011

First Edition: July 28, 2011

In today's headlines, reports about the ever-growing US health health care tab and about the petition filed by a conservative legal center to bring their health law challenge to the Supreme Court.

28 Jul 2011

Yaupon seeks FDA marketing approval of mechlorethamine gel for mycosis fungoides

Yaupon Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its propriety gel formulation of mechlorethamine hydrochloride (mechlorethamine).

28 Jul 2011

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued in October 2010 by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), an investigational medication for type 2 diabetes.

28 Jul 2011

Curis second quarter net loss increases to $4.9 million

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.

28 Jul 2011

Physiological instability precedes an hour before naturally occurring panic attacks

Panic attacks that seem to strike sufferers out-of-the-blue are not without warning after all, according to new research.

28 Jul 2011

All Canadian provinces except Quebec announce funding agreement for PNH drug, Soliris

L'Association Québécoise de l'HPN regrets that Quebec remains one of the only jurisdictions in the developed world to decline including the only effective life-saving treatment against an ultra-rare blood disease - paroxysmal nocturnal hemoglobinuria (PNH) - on its public drug insurance plan drugs list.

28 Jul 2011

New candidate gene for human benign childhood epilepsies

A new epilepsy gene, LGI2, has been found in the Lagotto Romagnolo dogs, known from their gift for truffle hunting. The gene discovery made by Professor Hannes Lohi and his research group at the University of Helsinki and the Folkhälsan Rsearch Center offers a new candidate gene for human benign childhood epilepsies characterized by seizure remission.

28 Jul 2011

Celgene reports second quarter total revenue of $1.18 billion

Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.

28 Jul 2011

NeuroMetrix second quarter total revenues decrease to $2.6 million

NeuroMetrix, Inc., a science-based health care company improving patient care through neurotechnology, today reported business and financial highlights for the quarter and six months ended June 30, 2011.

28 Jul 2011

New approaches to improve biomarker discovery

An article in the current edition of Chemical & Engineering News, ACS's weekly newsmagazine, describes the trials, tribulations, and triumphs of one of the hottest pursuits in modern biomedical science - the search for "biomarkers" that could greatly improve the diagnosis of disease and efforts to monitor the effectiveness of treatment.

28 Jul 2011

GE's Innova imaging systems maintain quality at lower dose rates under live fluoroscopy

As the number of interventional procedures to diagnose and treat patients increases worldwide, and the procedures grow in complexity and length, exposure to radiation is a growing concern for both clinicians and patients.

28 Jul 2011

Cigarette smoke exposure alters airway tissue in people with COPD

Cigarette smoke exposure fundamentally alters airway tissue from people with chronic obstructive pulmonary disease (COPD) at the cellular level, laying the groundwork for airway thickening and even precipitating precancerous changes in cell proliferation that may be self-perpetuating long after cigarette smoke exposure ends, according to Australian researchers.

28 Jul 2011

Relative muscle mass inversely linked with insulin resistance and pre-diabetes

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that the greater an individual's total muscle mass, the lower the person's risk of having insulin resistance, the major precursor of type 2 diabetes.

28 Jul 2011

Solazyme launches anti-aging skincare line, Algenist at Space NK stores

Solazyme, Inc., a renewable oil and bioproducts company, has signed a distribution agreement with the United Kingdom's most innovative beauty retailer, Space NK, to expand the sales network of the company's luxury skincare line, Algenist, to include all 60 Space NK stores throughout the country.

28 Jul 2011